02.06.15
Eden Prairie, Minn.-based SurModics Inc. is down to eight board members as Gerald B. Fischer steps down for health reasons. At present, the board does not intend to fill the vacancy created as a result of Fischer’s retirement as it is the company’s intention to reduce the size of the board over time.
Fischer, who joined the board in 2002, was the former president and CEO of the University of Minnesota Foundation. During his time with SurModics, he served on the audit and corporate governance and nominating committees and helped guide SurModics through a number of significant milestones in the company’s evolution.
“On behalf of our Board and the SurModics management team, we thank Jerry for his outstanding service and longstanding commitment to the company,” said Scott Ward, chairman of the board. “Jerry has been an extraordinary board member, and we greatly appreciate the leadership, insight and financial expertise he has provided over the past 12 years. We are grateful for his thoughtful guidance, and we wish him all the best in the future.”
CEO Gary Maharaj added, “I have enjoyed and benefited from Jerry's service to the board. I will greatly miss his collaborative leadership style, deeps insights and sage counsel.”
SurModics makes surface modification technologies and in vitro diagnostic chemical components for medical devices.
Fischer, who joined the board in 2002, was the former president and CEO of the University of Minnesota Foundation. During his time with SurModics, he served on the audit and corporate governance and nominating committees and helped guide SurModics through a number of significant milestones in the company’s evolution.
“On behalf of our Board and the SurModics management team, we thank Jerry for his outstanding service and longstanding commitment to the company,” said Scott Ward, chairman of the board. “Jerry has been an extraordinary board member, and we greatly appreciate the leadership, insight and financial expertise he has provided over the past 12 years. We are grateful for his thoughtful guidance, and we wish him all the best in the future.”
CEO Gary Maharaj added, “I have enjoyed and benefited from Jerry's service to the board. I will greatly miss his collaborative leadership style, deeps insights and sage counsel.”
SurModics makes surface modification technologies and in vitro diagnostic chemical components for medical devices.